Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo.
Munzen ME, Reguera Gomez M, Hamed MF, Enriquez V, Charles-Niño CL, Dores MR, Alviña K, Martinez LR.
Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0045923. doi: 10.1128/aac.00459-23. Epub 2023 Sep 26.
Cryptococcus neoformans, a global threat to human health.
Zhao Y, Ye L, Zhao F, Zhang L, Lu Z, Chu T, Wang S, Liu Z, Sun Y, Chen M, Liao G, Ding C, Xu Y, Liao W, Wang L.
Infect Dis Poverty. 2023 Mar 17;12(1):20. doi: 10.1186/s40249-023-01073-4.
[Cerebral cryptococcomas].
Woeffray MJ, Aguirre AR, Saguier Padilla I, Kinjo BL, Folgar SS, Mercado FCB.
Medicina (B Aires). 2024;84(4):793.
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
Ngan NTT, Flower B, Day JN.
Drugs. 2022 Aug;82(12):1237-1249. doi: 10.1007/s40265-022-01757-5. Epub 2022 Sep 16.
Infratentorial cerebral cryptococcosis.
Borresen TE, Hunter DR.
J Neuroimaging. 1995 Jan;5(1):48-9. doi: 10.1111/jon19955148.
Cryptococcal pericarditis.
Kurahara Y.
QJM. 2022 Aug 13;115(8):541-542. doi: 10.1093/qjmed/hcac141.
Treatment of cryptococcosis in non-HIV immunocompromised patients.
Henao-Martínez AF, Chastain DB, Franco-Paredes C.
Curr Opin Infect Dis. 2018 Aug;31(4):278-285. doi: 10.1097/QCO.0000000000000458.
Cryptococcal meningitis.
Ming DK, Harrison TS.
Br J Hosp Med (Lond). 2017 Aug 2;78(8):C125-C127. doi: 10.12968/hmed.2017.78.8.C125.
Cryptococcosis in AIDS.
Imwidthaya P, Poungvarin N.
Postgrad Med J. 2000 Feb;76(892):85-8. doi: 10.1136/pmj.76.892.85.
Overwhelming cryptococcosis complicated by cryptococcal endocarditis.
Elkhatib W, Kwon JY, Phillips MB.
BMJ Case Rep. 2022 Mar 2;15(3):e247310. doi: 10.1136/bcr-2021-247310.
